- Home
- FRST vs AARD Comparison
FRST vs AARD Comparison
Compare FRST & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRST | AARD |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.2M | 281.1M |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | FRST | AARD |
|---|---|---|
| Price | $12.84 | $5.38 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $19.63 |
| AVG Volume (30 Days) | 82.7K | ★ 401.3K |
| Earning Date | 04-27-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.13% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.54 | N/A |
| P/E Ratio | $9.91 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.60 | $4.74 |
| 52 Week High | $14.55 | $17.94 |
Technical Indicators
Market Signals| Indicator | FRST | AARD |
|---|---|---|
| Relative Strength Index (RSI) | 38.62 | 25.44 |
| Support Level | $12.52 | $4.74 |
| Resistance Level | $14.42 | $6.19 |
| Average True Range (ATR) | 0.40 | 0.54 |
| MACD | -0.06 | -0.23 |
| Stochastic Oscillator | 29.71 | 7.71 |
Price Performance
Historical ComparisonAbout FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit. Its operating segments are Primis Mortgage, Primis Bank, and Other.
About AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.